Insider Buy/Sell Details for the Healthcare Sector — Last 3 Months
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (5459)
ZEVRA THERAPEUTICS, INC. (ZVRA)
McFarlane Neil F. — Director
Shares
14,625
Price
$8.56
Total Value
$125.19K
Shares Held After
387,225
% of Holdings
3.6%
Biogen Inc. (BIIB)
Singhal Priya — Head of Development
Shares
2,660
Price
$199.83
Total Value
$531.55K
Shares Held After
8,043
% of Holdings
24.9%
LABCORP HOLDINGS INC. (LH)
Meltzer Jonathan C — EVP, Operations
Shares
88
Price
$275.53
Total Value
$24.25K
Shares Held After
2,869
% of Holdings
3.0%
RESMED INC (RMD)
Farrell Michael J. — Director
Shares
4,991
Price
$273.78
Total Value
$1.37M
Shares Held After
466,223
% of Holdings
1.1%
Syndax Pharmaceuticals, Inc. (SNDX)
Metzger Michael A — Director
Shares
17,159
Price
$21.03
Total Value
$360.82K
Shares Held After
491,690
% of Holdings
3.4%
Syndax Pharmaceuticals, Inc. (SNDX)
Goldan Keith A. — Chief Financial Officer
Shares
3,410
Price
$21.03
Total Value
$71.71K
Shares Held After
140,429
% of Holdings
2.4%
Nurix Therapeutics, Inc. (NRIX)
Ring Christine — Chief Legal Officer
Shares
14,261
Price
$16.66
Total Value
$237.62K
Shares Held After
42,749
% of Holdings
25.0%
ENSIGN GROUP, INC (ENSG)
Parkinson Mark Vincent — Director
Shares
100
Price
$198.00
Total Value
$19.80K
Shares Held After
2,900
% of Holdings
3.3%
ENSIGN GROUP, INC (ENSG)
Blouin Ann Scott — Director
Shares
375
Price
$198.00
Total Value
$74.25K
Shares Held After
22,852
% of Holdings
1.6%
Merck & Co., Inc. (MRK)
Zachary Jennifer — EVP, General Counsel
Shares
38,835
Price
$119.15
Total Value
$4.63M
Shares Held After
68,916
% of Holdings
36.0%
Merck & Co., Inc. (MRK)
Zachary Jennifer — EVP, General Counsel
Shares
56,792
Price
$119.15
Total Value
$6.77M
Shares Held After
68,916
% of Holdings
45.2%
Merck & Co., Inc. (MRK)
Zachary Jennifer — EVP, General Counsel
Shares
25,946
Price
$119.15
Total Value
$3.09M
Shares Held After
68,916
% of Holdings
27.4%
Merck & Co., Inc. (MRK)
Guindo Chirfi — Chief Marketing Officer
Shares
10,000
Price
$118.41
Total Value
$1.18M
Shares Held After
70,615
% of Holdings
12.4%
EKSO BIONICS HOLDINGS, INC. (EKSO)
ASHER DANIEL — 10% Owner
Shares
194
Price
$9.86
Total Value
$1.91K
Shares Held After
156,957
% of Holdings
0.1%
Zentalis Pharmaceuticals, Inc. (ZNTL)
EASTLAND JULIA MARIE — Director
Shares
7,866
Price
$2.43
Total Value
$19.11K
Shares Held After
80,022
% of Holdings
9.0%
Zentalis Pharmaceuticals, Inc. (ZNTL)
Bruns Ingmar — Chief Medical Officer
Shares
2,962
Price
$2.43
Total Value
$7.20K
Shares Held After
33,667
% of Holdings
8.1%
Zentalis Pharmaceuticals, Inc. (ZNTL)
Vultaggio Vincent — PAO and PFO
Shares
29,951
Price
$2.43
Total Value
$72.77K
Shares Held After
156,779
% of Holdings
16.0%
Cingulate Inc. (CING)
Brams Matthew — EVP and Chief Medical Officer
Shares
1,946
Price
$5.04
Total Value
$9.81K
Shares Held After
4,656
% of Holdings
41.8%
Cingulate Inc. (CING)
Schaffer Shane J. — Director
Shares
6,809
Price
$5.04
Total Value
$34.32K
Shares Held After
10,175
% of Holdings
66.9%
Cingulate Inc. (CING)
Callahan Jennifer L. — SVP and CFO
Shares
4,864
Price
$5.04
Total Value
$24.51K
Shares Held After
5,059
% of Holdings
96.1%
Cingulate Inc. (CING)
Werth Peter J. — Director
Shares
19,455
Price
$5.04
Total Value
$98.05K
Shares Held After
117,449
% of Holdings
16.6%
Enliven Therapeutics, Inc. (ELVN)
Lyssikatos Joseph P — CHIEF SCIENTIFIC OFFICER
Shares
5,000
Price
$29.04
Total Value
$145.22K
Shares Held After
740,188
% of Holdings
0.7%
IONIS PHARMACEUTICALS INC (IONS)
Monia Brett P — Director
Shares
29,430
Price
$85.79
Total Value
$2.52M
Shares Held After
254,497
% of Holdings
10.4%
Cardinal Health, Inc. (CAH)
Hall Patricia Hemingway — Director
Shares
4,000
Price
$229.72
Total Value
$918.88K
Shares Held After
28,264
% of Holdings
12.4%
Spero Therapeutics, Inc. (SPRO)
Keutzer Timothy — Chief Operating Officer
Shares
18,652
Price
$2.36
Total Value
$44.02K
Shares Held After
742,506
% of Holdings
2.5%
Spero Therapeutics, Inc. (SPRO)
Rajavelu Esther — Chief Executive Officer, Chief Financial Officer and Chief Business Officer
Shares
50,816
Price
$2.36
Total Value
$119.93K
Shares Held After
1,012,091
% of Holdings
4.8%
Spero Therapeutics, Inc. (SPRO)
Rajavelu Esther — Chief Executive Officer, Chief Financial Officer and Chief Business Officer
Shares
37,101
Price
$2.36
Total Value
$87.56K
Shares Held After
1,062,907
% of Holdings
3.4%
MCKESSON CORP (MCK)
Rutledge Napoleon B JR — SVP, Controller & CAO
Shares
328
Price
$955.00
Total Value
$313.24K
Shares Held After
0
% of Holdings
100.0%
ENSIGN GROUP, INC (ENSG)
Snapper Suzanne D. — Director
Shares
100
Price
$197.21
Total Value
$19.72K
Shares Held After
272,889
% of Holdings
0.0%
ENSIGN GROUP, INC (ENSG)
Snapper Suzanne D. — Director
Shares
2,268
Price
$196.11
Total Value
$444.77K
Shares Held After
272,989
% of Holdings
0.8%
ENSIGN GROUP, INC (ENSG)
Snapper Suzanne D. — Director
Shares
2,205
Price
$196.07
Total Value
$432.33K
Shares Held After
275,257
% of Holdings
0.8%
CODEXIS, INC. (CDXS)
MOORE ALISON — Director
Shares
3,826
Price
$1.31
Total Value
$5.00K
Shares Held After
250,506
% of Holdings
1.5%
CODEXIS, INC. (CDXS)
Erbez Georgia — Chief Financial Officer and Chief Business Officer
Shares
3,826
Price
$1.31
Total Value
$5.00K
Shares Held After
66,810
% of Holdings
5.4%
CODEXIS, INC. (CDXS)
Lutz Stefan — Chief Scientific Officer
Shares
2,492
Price
$1.31
Total Value
$3.26K
Shares Held After
136,283
% of Holdings
1.8%
Cocrystal Pharma, Inc. (COCP)
FROST PHILLIP MD ET AL — Director
Shares
50,000
Price
$0.95
Total Value
$47.28K
Shares Held After
1,888,551
% of Holdings
2.6%
GALECTIN THERAPEUTICS INC (GALT)
ELDRED KARY — Director
Shares
300
Price
$2.70
Total Value
$810.00
Shares Held After
65,682
% of Holdings
0.5%
Twist Bioscience Corp (TWST)
JOHANNESSEN JAN — Director
Shares
2,200
Price
$47.91
Total Value
$105.39K
Shares Held After
17,754
% of Holdings
11.0%
Syndax Pharmaceuticals, Inc. (SNDX)
Goldan Keith A. — Chief Financial Officer
Shares
2,082
Price
$20.62
Total Value
$42.93K
Shares Held After
143,839
% of Holdings
1.4%
Syndax Pharmaceuticals, Inc. (SNDX)
Metzger Michael A — Director
Shares
7,412
Price
$20.62
Total Value
$152.84K
Shares Held After
508,849
% of Holdings
1.4%
Protagonist Therapeutics, Inc (PTGX)
Waddill William D. — Director
Shares
20,000
Price
$83.68
Total Value
$1.67M
Shares Held After
7,825
% of Holdings
71.9%
Merck & Co., Inc. (MRK)
DeLuca Richard R. — EVP&Pres, Merck Animal Heallth
Shares
37,685
Price
$120.92
Total Value
$4.56M
Shares Held After
160,174
% of Holdings
19.0%
Merck & Co., Inc. (MRK)
Oosthuizen Johannes Jacobus — President, U.S. Market
Shares
15,000
Price
$121.87
Total Value
$1.83M
Shares Held After
21,197
% of Holdings
41.4%
Merck & Co., Inc. (MRK)
Williams David Michael — EVP,Chief Info&Digital Officer
Shares
5,000
Price
$121.91
Total Value
$609.52K
Shares Held After
30,838
% of Holdings
14.0%
ENSIGN GROUP, INC (ENSG)
Snapper Suzanne D. — Director
Shares
727
Price
$197.68
Total Value
$143.71K
Shares Held After
277,462
% of Holdings
0.3%
ENSIGN GROUP, INC (ENSG)
Snapper Suzanne D. — Director
Shares
1,595
Price
$196.87
Total Value
$314.01K
Shares Held After
278,189
% of Holdings
0.6%
ENSIGN GROUP, INC (ENSG)
Snapper Suzanne D. — Director
Shares
2,072
Price
$196.01
Total Value
$406.13K
Shares Held After
279,784
% of Holdings
0.7%
ENSIGN GROUP, INC (ENSG)
Snapper Suzanne D. — Director
Shares
1,742
Price
$194.96
Total Value
$339.63K
Shares Held After
281,856
% of Holdings
0.6%
ENSIGN GROUP, INC (ENSG)
Snapper Suzanne D. — Director
Shares
644
Price
$193.52
Total Value
$124.63K
Shares Held After
283,598
% of Holdings
0.2%
ENSIGN GROUP, INC (ENSG)
Snapper Suzanne D. — Director
Shares
550
Price
$192.09
Total Value
$105.65K
Shares Held After
284,242
% of Holdings
0.2%
ENSIGN GROUP, INC (ENSG)
Snapper Suzanne D. — Director
Shares
200
Price
$187.28
Total Value
$37.46K
Shares Held After
284,792
% of Holdings
0.1%
Showing 3001–3050 of 5459 transactions (page 61 of 110)